Source: Glacial Gold
  • Nextleaf Solutions (OILS)  is supplying Hybrid Pharm with the entire suite of Glacial Gold™ cannabinoid-based products
  • Ottawa-based Hybrid Pharm offers medical cannabis patients a full in-store experience and Tele-Medicine platform
  • Nextleaf is a federally regulated cannabis oil producer that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids
  • Nextleaf Solutions Ltd. (OILS) opened trading at C$0.135 per share

Nextleaf Solutions (OILS)  is supplying Hybrid Pharm with the entire suite of Glacial Gold™ cannabinoid-based products.

“Hybrid Pharm’s dedication to the plant, patient education, and unique model of distribution through brick-and-mortar pharmacy made it a must for our company when considering making Glacial Gold available for medical use,” said Nextleaf CEO Paul Pedersen.

“We are proud to have Glacial Gold products distributed by Hybrid Pharm in store and online, and excited to support increased access to medical cannabis through the growth of Hybrid’s pharmacy distribution model across Canada.”

Ottawa-based Hybrid Pharm provides medical cannabis patients with a full in-store experience while still offering a Tele-Medicine platform. Certified medical staff ensure patients’ cannabis treatments are optimized through close monitoring, drug interaction checks, and quality control processes.

Hybrid Pharm’s pharmacists are equipped to help patients learn about cannabis and their needs, including dosage forms and side effects. Patients with Hybrid Pharm have access to informative workshops and seminars through their website. “Patients deserve an outlet to discuss their medical cannabis needs and like all drugs, medical cannabis is best dispensed by qualified pharmacists. Recreational cannabis stores cannot offer this expertise,” said Dr. Rahim Dhalla, Chief Executive Officer of Hybrid Pharm.

Nextleaf is a federally regulated cannabis oil producer that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids.

Nextleaf Solutions Ltd. (OILS) opened trading at C$0.135 per share.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.